PreviPharma Consulting GmbH is an internationally active research and development company. Together with partners in plasma fractionation, plasma donation centers, and technology suppliers, our team develops new medical and technological solutions from plasma donation to the finished therapy product. Plasma industry including recombinant proteins has grown to more than $ 20 billion of annual sales. However, only few more than 10 out of approximately 2500 plasma proteins are presently available for therapeutic use. Significant market potential exceeding the present market is left untapped. PreviPharma’s MIP (Medical Innovation Platform) has identified several early stage drug candidates and created significant data packages. All of them are developed for indications with substantial market potential. These include various therapeutic areas such as hematology, infectious disease, gastrointestinal indications, neurology, and inflammation.

PreviPharma

Satish Kumar Devarapu

This department focuses on scientific research and innovative development of new products and technologies.

Research and Development

This department conducts scientific research and experiments to advance knowledge in various fields.

Research Science

This department provides diagnostic and therapeutic services related to medical technology.

Clinical Services

This department conducts scientific research to advance knowledge and innovation in various fields.

Research Sciences

This department provides assistance and solutions for technical issues and inquiries.

PreviPharma

Org chart

Teams

Research and Development

Research Science

Clinical Services

Research Sciences

Technical Support

Offices

PreviPharma

Org chart

Teams

Research and Development

Research Science

Clinical Services

Research Sciences

Technical Support

Offices

Related companies